Journal
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 173, Issue 10, Pages 2584-2595Publisher
WILEY
DOI: 10.1002/ajmg.a.38357
Keywords
perioperative management; skeletal dysplasias
Categories
Funding
- Bio Marin Pharmaceuticals
- Alexion Pharmaceuticals
- Growing Stronger Foundation
- Ultragenyx Pharmaceuticals
- Michael Goldberg Skeletal Dysplasia Fund
- Camp Korey
- Genzyme
Ask authors/readers for more resources
Patients with skeletal dysplasia frequently require surgery. This patient population has an increased risk for peri-operative complications related to the anatomy of their upper airway, abnormalities of tracheal-bronchial morphology and function; deformity of their chest wall; abnormal mobility of their upper cervical spine; and associated issues with general health and body habitus. Utilizing evidence analysis and expert opinion, this study aims to describe best practices regarding the peri-operative management of patients with skeletal dysplasia. A panel of 13 multidisciplinary international experts participated in a Delphi process that included a thorough literature review; a list of 22 possible care recommendations; two rounds of anonymous voting; and a face to face meeting. Those recommendations with more than 80% agreement were considered as consensual. Consensus was reached to support 19 recommendations for best pre-operative management of patients with skeletal dysplasia. These recommendations include pre-operative pulmonary, polysomnography; cardiac, and neurological evaluations; imaging of the cervical spine; and anesthetic management of patients with a difficult airway for intubation and extubation. The goals of this consensus based best practice guideline are to provide a minimum of standardized care, reduce perioperative complications, and improve clinical outcomes for patients with skeletal dysplasia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available